Descriptor English: | Azathioprine |
Descriptor Spanish: | Azatioprina |
Descriptor Portuguese: | Azatioprina |
Descriptor French: | Azathioprine |
Entry term(s): |
Azathioprine Sodium Azathioprine Sodium Salt Azathioprine Sulfate Azothioprine Immuran Imuran Imurel Sodium, Azathioprine |
Tree number(s): |
D02.886.759.111 D03.633.100.759.570.090 D13.570.900.111 |
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D001379 |
Scope note: | An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) |
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
Pharm Action: |
Antimetabolites Antimetabolites, Antineoplastic Immunosuppressive Agents Antirheumatic Agents |
Registry Number: | MRK240IY2L |
CAS Type 1 Name: | 1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)- |
Public MeSH Note: | 66 |
History Note: | 66(64) |
DeCS ID: | 1394 |
Unique ID: | D001379 |
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents |
Date Established: | 1966/01/01 |
Date of Entry: | 1999/01/01 |
Revision Date: | 2018/07/05 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Azathioprine
- Preferred
Imurel
- Narrower
Imuran
- Narrower
Azathioprine Sodium
- Narrower
Azathioprine Sulfate
- Narrower
Concept UI |
M0002065 |
Scope note | An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) |
Preferred term | Azathioprine |
Entry term(s) |
Azothioprine |
Concept UI |
M0002067 |
Preferred term | Imurel |
Concept UI |
M0002066 |
Preferred term | Imuran |
Entry term(s) |
Immuran |
Concept UI |
M0331325 |
Preferred term | Azathioprine Sodium |
Entry term(s) |
Azathioprine Sodium Salt Sodium, Azathioprine |
Concept UI |
M0331324 |
Preferred term | Azathioprine Sulfate |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey